Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025

businesswire.com
BMY

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
AMGN PFE LLY AZN BMY NVS SNY GSK UCB ARQT REGN INCY ABBV BIIB MRK JNJ VNDA RAPT CHAI ONON ION ASMB CRVS APG KSCP KYMR XBI IBB ADSK CDNS SNPS

Global Demand Spurs Competition in CAR T-Cell Therapy for Multiple Myeloma

globenewswire.com
BMY JNJ NVS GILD

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference

globenewswire.com
AMGN REGN GILD BMY AZN NVS ARGX BIIB BBIO SRRK

K36 Therapeutics announces presentation of First-in-Human Clinical Data for Gintemetostat (KTX-1001) Demonstrating Target Engagement and Clinical Activity in Multiple Myeloma at ASH 2025 and the Appointment of Dr. Shinta Cheng, M.D., Ph.D., as Chief

prnewswire.com
SWX JNJ BMY

Immunotherapy Drugs Research Report 2025: $526.5 Bn Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2034

globenewswire.com
AMGN PFE JNJ BMY GILD MRK MDT ADAP

Companion Diagnostics Market Research 2025: $21+ Bn Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2024-2034

globenewswire.com
PFE MRK AZN TMO ABT AMGN JNJ BMY LLY MYGN GRDX BIIB BDX

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

globenewswire.com
BMY GILD NVS

Tigerlily Foundation Launches the "Bliss Collective: Brunch & Sip" Series to Empower, Educate, and Uplift Women Nationwide

prnewswire.com
BMY

Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight

globenewswire.com
JAZZ PRE ABBV AMGN GILD BMY AZN INCY PFE CELC